期刊文献+

SDF-1α改善高糖对骨髓间充质干细胞存活及迁移能力的抑制作用与分子机制的研究 被引量:5

SDF-1α attenuates the inhibitory effect of high-glucose on rat mesenchymal stem cells survival and migration and the underlying molecular mechanisms
下载PDF
导出
摘要 目的:探讨基质细胞衍生因子-1α(SDF-1α)对高糖环境(25 mmol/L)下大鼠骨髓间充质干细胞(r MSCs)存活及迁移能力的影响及相关分子机制.方法:采用全髓贴壁法纯化培养r MSCs,通过MTT法检测细胞增殖率、Hoechst 33258染色从形态学角度观察细胞凋亡评估SDF-1α对高糖环境下r MSCs存活的影响,同时通过transwell实验评估SDF-1α对高糖环境下r MSCs细胞迁移能力的影响.结果:实验结果发现,与低糖培养液(5.6mmol/L)比较,高糖培养液可明显抑制r MSCs增殖、促进细胞凋亡(P<0.05),SDF-1α(50 ng/m L)可减轻高糖培养液对细胞增殖的抑制及诱导细胞凋亡的作用(P<0.05),CXCR4受体特异性拮抗剂AMD3100(10μg/m L)虽能进一步抑制细胞增殖、诱导细胞凋亡,但差异无显著性(P>0.05).Transwell实验发现高糖培养液可明显抑制r MSCs的迁移作用(P<0.05),SDF-1α(50 ng/m L)可逆转高糖培养液对细胞迁移的抑制作用(P<0.05),AMD3100(10μg/m L)可进一步抑制细胞迁移,且差异有显著性(P<0.05).结论:SDF-1α可能通过CXCR4受体改善高糖对骨髓间充质干细胞迁移能力的抑制,而其改善高糖对骨髓间充质干细胞存活的抑制则可能通过非CXCR4受体介导,为改善MSCs用于治疗冠心病合并糖代谢异常患者心梗后心力衰竭疗效进一步提供理论依据. Aim:To explore the influence of SDF-1αon the inhibitory effect of high-glucose (25 mmol/L)to rat mesenchymal stem cells survival and migration.Methods:The survival of MSCs in dif-ferent groups was examined by MTT assay for proliferation and Hoechst 33258 staining for apoptosis.The migration of MSCs in different groups was assessed by Transwell assay.Results:Compared with low-glu-cose (5.6mmol /L),high-glucose inhibits rat mesenchymal stem cells survival and migration (P 0.05),SDF-1αcan attenuate such inhibitory effects (vs high-glucose,P 〈0.05).&nbsp;Conclusion:SDF-1αattenuates the inhibitory effect of high-glucose on rat mesenchymal stem cell migra-tion via CXCR4 receptor,while it may attenuate the inhibitory effect of high-glucose on rat mesenchymal stem cells survival via binding to non-CXCR4 receptor.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2015年第2期136-142,共7页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家自然科学基金青年项目(81100078) 教育部科学研究重点项目(211207) 广东省科技厅博士启动项目(S2011040001392) 广州珠江科技新星资助计划项目(2012J2200063)
关键词 骨髓间充质干细胞 基质细胞衍生因子 -1α 凋亡 迁移 mesenchymal stem cells SDF-1α apoptosis migration
  • 相关文献

参考文献16

  • 1CHOI Y H, KURTZ A, STAMM C. Mesenchymal stem cells for cardiac cell therapy [ J ]. Hum Gene Ther, 2011, 22: 3-17.
  • 2LI Z, GUO J, CHANG Q, ZHANG A. Paracrine role for mesenchymal stem cells in acute myocardial infarction [J]. Biol Pharm Bull, 2009, 32:1343 -1346.
  • 3HELDMAN A W, DIFEDE D L, FISHMAN J E, et al. Transendocardial mesenchymal stem cells and mononucle- ar bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial[ J ]. JAMA, 2014,311 : 62 - 73.
  • 4HARE J M, FISHMAN J E, GERSTENBLITH G, et al. Comparison of allogeneic vs autologous bone marrow-de- rived mesenchymal stem cells delivered by transendocar- dial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial[ J ]. JAMA, 2012,308 : 2369 - 2379.
  • 5TEMPLIN C, ZWEIGERDT R, SCHEWANKE K, OLMER R, et al. Transplantation and tracking of human- induced pluripotent stem ceils in a pig model of myocardi- al infarction assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide sym- porter transgene expression [ J ]. Circulation, 2012,126 : 430 - 439.
  • 6YANG K, WANG X Q, HE Y S, et al. Advanced glyca- tion end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells [ J ]. Cardiovasc Diabetol, 2010,9:66.
  • 7DHANASEKARAN M, INDUMATHI S, RAJKUMAR J S, et al. Effect of high glucose on extensive culturing of mesenchymal stem cells derived from subcutaneous fat, o- mentum fat and bone marrow cell biochemistry and func- tion[J]. Cell Biochem Funct, 2013, 31:20-29.
  • 8LI Y M, SCHILLING T, BENISCH P, et al. Effects of high glucose on mesenchymal stem cell proliferation and differentiation [ J ]. Biochem Biophys Res Commun, 2007,363:209 - 215.
  • 9KHAN M, AKHTAR S, MOHSIN S, et al. Growth Fac- tor Preconditioning Increases the Function of Diabetes-Im- paired Mesenehymal Stem Cells [ J]. Stem Cells Dev, 2011,20:67 - 75.
  • 10ISHIZUKA T, HINATA T, WATANABE Y. Superoxide induced by a high-glucose concentration attenuates pro- duction of angiogenic growth factors in hypoxic mouse mesenchymal stem cells [ J ]. J Endocrinol, 2011,208 : 147 - 159.

同被引文献95

  • 1李丹,范哲,张晓威.急性百草枯中毒机制及沙利度胺的治疗前景[J].中国老年学杂志,2014,34(2):549-552. 被引量:6
  • 2Kim HJ, Yeom JS, Koh YG, et al. Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-alpha and IL-I[J]. J Orthop Res, 2014. 32 (4): 551-556.
  • 3Mavrogonatou E, Angelopoulou MT, Kletscas D, et al. The catabolic effect of TNFalpha on bovine nucleus pulposus intervertebral disc cells and the restraining role of glucosamine sulfate in the TNFalpha-mediated up-regulation of MMP-3[J]. J Orthop Res, 2014. 32(12): 1701-1707.
  • 4Zhengjun Bian, Jianhua Sun. Development of a KLD-12 polypeptide,q'GF-l-tissue scaffold promoting the differentia- tion of mesenchymal stem cell into nucleus pulposus-like cells for treatment of intervertebral disc degeneration[J]. Int J Clin Exp Pathol, 2015, 8(2): 1093-1103.
  • 5Morigele M, Shao Z, Zhang Z, et al. TGF-betal induces a nucleus pulposus-like phenotype in Notch 1 knockdown rabbit bone marrow mesenchymal stem cells[J]. Cell Biol Int, 2013. 37(8): 820-825.
  • 6Kepler CK. The molecular basis of intervertebral disc degen- eration[J]. Spine J, 2013. 13(3): 318-330.
  • 7Liebscher T, Haefeli M, Wuertz K, et al. Age-related varia- tion in cell density of human lumbar intervertebral disc [J]. Spine (Phila Pa 1976), 2011. 36(2): 153-159.
  • 8Weiler C, Nerlich AG, Bachmeier BE, et al. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls[J]. Spine, 2005. 30(1): 44-53.
  • 9Sive JI, Baird P, Jeziorsk M, et al. Expression of chondro- cyte markers by cells of normal and degenerate intervertebral discs[J]. Mol Patbel, 2002. 55(2): 91-97.
  • 10Tian B, Li X, Kalita M, et al. Analysis of the TGFI3- induced program in primary airway epithelial cells shows essential role of NF-KB/RelA signaling network in type II epithelial mesenchymal transition[j]. BMC Genomics, 2015, 16: 529.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部